# Kodiak Sciences Inc (KOD) fundamentals

Data as of 2026-09-08. NASDAQ, United States. Sector: Healthcare / Biotechnology. Price $35.36, market value $2.2 billion.

## Valuation
- **P/E (trailing): n/a** (negative earnings). Kodiak Sciences Inc reported negative earnings over the last twelve months, so the P/E is not meaningful; use price-to-sales, EV/EBITDA and free-cash-flow yield instead.
- **Price / book: 36.3×**. The shares trade at 36.3× book value; most of the value is in earnings power and intangibles rather than the balance sheet.
- **Free-cash-flow yield: -7.2%** (5-yr avg -44.8%). Free cash flow is negative: the business is consuming cash, which is normal for heavy investment phases but a warning otherwise.

## Profitability
- **Return on equity: -146.1%**. Return on equity is negative because earnings are negative.

## Growth
- **EPS growth (1 yr): -29.0%**. Earnings per share fell 29.0%.

## Financial health
- **Current ratio: 4.72** (quick 4.72). Current assets cover the next year's liabilities 4.72 times.
- **Piotroski F-score: 1/9**. 1 of 9 checks pass: weak or deteriorating financials.

## Dividends
- **Dividend: none**. Kodiak Sciences Inc does not currently pay a dividend.

## Analyst view
- **Analyst consensus: strong_buy** (5 analysts). 5 analysts cover Kodiak Sciences Inc; the consensus is strong_buy, with an average price target of $69.60 (+97% from the current price). Analyst opinion is shown for context; it is not part of the Fundamental Score.

## Price and momentum
- **Total return (1 yr): 313.6%** (YTD 26.5%, 3-mo 13.9%). The shares are up 313.6% over twelve months including dividends.
- **From 52-week high: -26.1%** (296.9% above the low). Trading 26% below its 52-week high.
- **200-day average: above**. The price sits above its 200-day moving average, the usual definition of an uptrend.
- **RSI (14-day): 35**. An RSI of 35 is neutral.
- **Beta (1 yr): 1.23** (volatility 128%). Beta of 1.23 against the S&P 500: the shares move roughly with the market.

Live score and charts: https://foliofundamentals.com/analyzer?s=KOD · Page: https://foliofundamentals.com/stocks/kod

Not investment advice.